Bjorkquist Jeanette M's Form 4 filing
Assembly Biosciences, Inc. (ASMB) · filed Mar 31, 2023
- Accession no.
- 0001209191-23-021882
- Filed
- Mar 31, 2023
- Trade date
- Feb 16-Mar 30, 2023
- Filing delay
- 43 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $634.68. It was filed 43 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bjorkquist Jeanette MCIK 0001945064 | Officer (Principal Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Common Stock | AGrant or awardAcquired | +6,250 | $0.00 | $0 | 24,580 | Direct | |
| Mar 30, 2023 | Common Stock | SSaleDisposed | −774 | $0.82 | −$634.68 | 23,806 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Common Stock | AGrant or awardAcquired | +2,000 | $0.00 | $0 | 2,000 | Direct | |
| Mar 29, 2023 | Common Stock | AGrant or awardAcquired | +12,500 | $0.00 | $0 | 12,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.